Healthcare Adoption PKMAS and Zeno Walkway address rehab, amputation, orthopedic surgery, cerebral palsy, Parkinsonism, stroke, and education, making ProtoKinetics attractive to hospitals, clinics, and research centers seeking validated gait metrics. There is an opportunity to pursue multi-site deployments with enterprise licenses and ongoing service contracts, as well as integration with EMR/EHR systems and data export workflows to fit clinical and research pipelines.

Extended Gait Growth Recent PKMAS 6.0 enhancement enables rapid decomposition of gait data from extended protocols such as walking tests, which appeals to rehab programs and research labs performing 6-minute walk tests and long gait observations. Target buyers include neurology clinics, stroke rehab units, geriatric centers, and universities that value efficient, reproducible gait analysis.

Platform Services With a lean team, ProtoKinetics can monetize growth through scaled software modules, advanced analytics, dashboards, training, and remote support. Propose offering maintenance contracts, cloud hosting, and data analytics add-ons as recurring revenue, alongside professional services for installation, onboarding, and protocol setup.

Education Market The product suite is well positioned for education and research markets. Opportunities exist to license to universities and research labs, collaborate on gait studies, and provide academic pricing or grant-funded purchases, while building case libraries and data partnerships.

Competitive Position ProtoKinetics competes in a specialized segment with players like Vicon, Bertec, OptiTrack, and Motion Analysis. Strengthen competitive positioning through clinical relevance, validated metrics, and robust support, and explore channel partnerships, resellers, and targeted marketing to hospitals, clinics, and rehabilitation centers, with plans for scalability and potential international expansion.